By offering an additional Board meeting, Quorum is maximizing opportunities for more efficient ethics review.
Seattle, WA (PRWEB) March 27, 2014
Quorum Review IRB, the industry leader in central IRB services, announces today the addition of a Monday Board meeting for research protocols and consent forms. The addition of this meeting gives Quorum a total of 15 Board meetings each week. The new Monday meeting is dedicated to the review of new clinical research protocols and consent forms. Quorum’s new Board meeting will convene every Monday afternoon beginning April 7, 2014.
Additionally, Quorum is adding a new North American Board meeting each week. The addition of a North American Board meeting reduces the wait time to have a North American study reviewed. Going forward, North American Board meetings will be held on Wednesdays and Fridays. The North American Board reviews studies performed in both the U.S. and Canada. Quorum will continue to hold its Cambridge-based oncology Board meeting on Tuesdays, and all of Quorum’s Boards are capable of reviewing studies beyond North America.
As Quorum Review CEO Cami Gearhart, JD, explains, the addition of the Monday meeting provides more flexibility and responsiveness to client needs: “By offering an additional Board meeting, Quorum is maximizing opportunities for more efficient ethics review. Adding capacity to our North American review from once to twice a week increases our ability to provide quick turnaround for our North American clients.”
Increasing Quorum’s Board review capacity for research sponsors, CROs, and investigators further augments Quorum’s already expedient review schedule and supports us in pursuit of our mission to provide the gold standard in customer service. More information on Quorum’s ethics review services can be found at http://www.quorumreview.com.
About Quorum Review
Quorum Review is an independent ethics review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing ethics review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human research subject protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH) and principles of the Belmont Report.
Quorum’s best-in-class service and support includes 15 Board meetings each week, plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and SmartForms for online submissions. Quorum’s service offerings include full study review in the US, as well as internationally; a specialized Phase I team; institution-specific support; and efficient processes for minimal risk studies.